Our Product
This is a unique health-screening product. Its value lies in the fact that this is a non-invasive, non-specific yet simple test that may eventually be used to indicate the presence of cancer at an early stage of development. Regular screening is essential in order to detect the cancer at an early stage. This is the unique selling point of our technology. If successful, our technology will allow individuals to monitor their health and provide a first indication of cancer. This will be particularly useful for people that want to monitor their remission or the efficacy of their cancer treatment. The purpose of this test is to alert individuals to a problem, and that they should seek further medical advice.
No other cancer test, that we are aware of, is both non-specific and non-invasive, though there are many products that can screen for specific cancers. Given the range of cancers, it is often neither practicable nor affordable for customers to undergo a large number of specific cancer screening tests. Many of the current cancer screening tests are expensive and can be quite invasive. This would make these tests on a regular basis unfeasible – even if they want to, thereby lowering their chances of very early detection. What is necessary is a general test that is simple and inexpensive enough for individuals to take on a regular basis. This product could offer all these benefits.
Introduction of this product into the healthcare market is very timely, given the rising incidence of cancer and an aging population. Regular testing, or monitoring, requires that the test be non-invasive (the proposed test requires simply a urine sample) and non-specific (since the patient cannot be expected to know in advance where a cancer will develop). It is our hope that this test could be used in connection with other testing technology, which may confirm or rule out a specific cancer, before or after symptoms have developed.
|